[HTML][HTML] Plasmodium falciparum Malaria Vaccines and Vaccine Adjuvants

SR Bonam, L Rénia, G Tadepalli, J Bayry, HMS Kumar - Vaccines, 2021 - mdpi.com
Malaria—a parasite vector-borne disease—is a global health problem, and Plasmodium
falciparum has proven to be the deadliest among Plasmodium spp., which causes malaria in …

[HTML][HTML] The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development

WL Mandala, V Harawa, F Dzinjalamala… - Molecular and …, 2021 - Elsevier
Plasmodium falciparum malaria still remains a major global public health challenge with
over 220 million new cases and well over 400,000 deaths annually. Most of the deaths occur …

[HTML][HTML] Seven-year efficacy of RTS, S/AS01 malaria vaccine among young African children

A Olotu, G Fegan, J Wambua… - … England Journal of …, 2016 - Mass Medical Soc
Background The candidate malaria vaccine RTS, S/AS01 is being evaluated in order to
inform a decision regarding its inclusion in routine vaccination schedules. Methods We …

[HTML][HTML] Hitting hotspots: spatial targeting of malaria for control and elimination

T Bousema, JT Griffin, RW Sauerwein, DL Smith… - PLoS …, 2012 - journals.plos.org
Hitting Hotspots: Spatial Targeting of Malaria for Control and Elimination | PLOS Medicine Skip
to main content Advertisement PLOS Medicine Browse Current Issue Journal Archive Special …

Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities

DA Helb, KKA Tetteh, PL Felgner… - Proceedings of the …, 2015 - National Acad Sciences
Tools to reliably measure Plasmodium falciparum (Pf) exposure in individuals and
communities are needed to guide and evaluate malaria control interventions. Serologic …

Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and …

DI Stanisic, FJI Fowkes, M Koinari, S Javati… - Infection and …, 2015 - Am Soc Microbiol
Individuals in areas of Plasmodium falciparum endemicity develop immunity to malaria after
repeated exposure. Knowledge of the acquisition and nature of protective immune …

Anti-PfGARP activates programmed cell death of parasites and reduces severe malaria

DK Raj, A Das Mohapatra, A Jnawali, J Zuromski… - Nature, 2020 - nature.com
Malaria caused by Plasmodium falciparum remains the leading single-agent cause of
mortality in children, yet the promise of an effective vaccine has not been fulfilled. Here …

Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection

DK Raj, CP Nixon, CE Nixon, JD Dvorin, CG DiPetrillo… - Science, 2014 - science.org
Novel vaccines are urgently needed to reduce the burden of severe malaria. Using a
differential whole-proteome screening method, we identified Plasmodium falciparum …

[HTML][HTML] Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection

L Foquet, CC Hermsen, GJ van Gemert… - The Journal of …, 2014 - Am Soc Clin Investig
Malaria, which is the result of Plasmodium falciparum infection, is a global health threat that
resulted in 655,000 deaths and 216 million clinical cases in 2010 alone. Recent phase 3 …

[HTML][HTML] Pareto rules for malaria super-spreaders and super-spreading

L Cooper, SY Kang, D Bisanzio, K Maxwell… - Nature …, 2019 - nature.com
Heterogeneity in transmission is a challenge for infectious disease dynamics and control. An
80-20 “Pareto” rule has been proposed to describe this heterogeneity whereby 80% of …